Jincheng Pharm Obtained Tobacco Production License in July 2023

Business by 2FIRSTS.ai

Dec.07.2023

Jincheng Pharm Obtained Tobacco Production License in July 2023

Jincheng Pharm replied to an investor's question about the amount of nicotine given by tobacco monopoly and its license.

On December 7th, an investor raised a question on an investor interaction platform, inquiring about the amount of nicotine used in e-cigarettes as well as the official data provided by the Tobacco Monopoly Bureau. The investor also sought information regarding the expected date for receiving the official notification.

Jincheng Pharm (300233.SZ) has responded that the company has obtained a new "Tobacco Monopoly Production Enterprise License" in July 2023, as disclosed on the Giant Wave Information Network. The company will organize production and sales in accordance with relevant laws, regulations, and regulatory authorities' requirements.

Also Read:

[1] Jincheng Pharm Releases Q3 2023 Financial Report and Obtains New License

[2] Jincheng Pharm Expands E-cigarette Business with Export Qualification

[3] Jincheng Pharm Reports Progress in Vaping Nicotine Project

#Legislation #E-cigarettes #Asia #Open system e-cigarettes #China #Regulation #Harm reduction products #Product #Products of Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Nov.14 by 2FIRSTS.ai

2Firsts Observation｜U.S. Launches Largest-Ever Vape Enforcement Drive as Federal and State Authorities Tighten Regulations

The U.S. has tightened vaping regulations nationwide. The DOJ, FDA, CBP and DEA seized millions of illegal devices in the largest-ever enforcement action. Several states introduced new laws with registries, packaging limits, and criminal penalties, signaling a shift toward institutionalized regulation and higher compliance costs.

Oct.17

Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance

Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.

Nov.12 by 2FIRSTS.ai

BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market

In BAT’s The Smokeless Word podcast, AACS CEO Theo Foukkare warned that high taxes and strict vape bans have fueled Australia’s AUD 10-billion illicit nicotine market and rising retail crime, urging urgent regulatory reform.